Equities

Medartis Holding AG

Medartis Holding AG

Actions
  • Price (CHF)51.50
  • Today's Change2.00 / 4.04%
  • Shares traded575.00
  • 1 Year change-19.66%
  • Beta1.5063
Data delayed at least 15 minutes, as of Nov 22 2024 10:39 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform3
Hold1
Sell0
Strong Sell0

Share price forecast in CHF

The 2 analysts offering 12 month price targets for Medartis Holding AG have a median target of 101.20, with a high estimate of 110.00 and a low estimate of 92.40. The median estimate represents a 104.44% increase from the last price of 49.50.
High122.2%110.00
Med104.4%101.20
Low86.7%92.40

Earnings history & estimates in CHF

Medartis Holding AG reported annual 2023 earnings of 0.20 per share on Mar 12, 2024.
Average growth rate-6.32%
More ▼

Revenue history & estimates in CHF

Medartis Holding AG had revenues for the full year 2023 of 212.01m. This was 15.96% above the prior year's results.
Average growth rate+13.59%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.